Tomohiro Enokida
National Cancer Center Hospital East(JP)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Head and Neck Cancer Studies, Immunotherapy and Immune Responses, Thyroid Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Lenvatinib for Anaplastic Thyroid Cancer(2017)189 cited
- → A Phase II Study of the Safety and Efficacy of Lenvatinib in Patients with Advanced Thyroid Cancer(2019)137 cited
- → A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma(2021)106 cited
- → Hematological immune related adverse events after treatment with immune checkpoint inhibitors(2021)86 cited
- → Vaccines for immunoprevention of cancer(2021)76 cited
- → Landscape of natural killer cell activity in head and neck squamous cell carcinoma(2020)64 cited
- → A T-cell-based immunogenicity protocol for evaluating human antigen-specific responses(2021)48 cited
- → Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study(2022)36 cited
- → A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck(2020)34 cited
- → Microbiota-driven antitumour immunity mediated by dendritic cell migration(2025)32 cited